Summary
MetLife Inc. reported its third-quarter 2025 financial results, showing a decrease in net income available to common shareholders to $818 million, or $1.22 per diluted share, compared to $1.3 billion, or $1.81 per diluted share, in the same period of 2024. This decline was primarily attributed to unfavorable changes in net investment gains/losses and significant unfavorable changes in net derivative gains/losses, largely due to currency movements and interest rate fluctuations. Despite the decline in net income, adjusted earnings available to common shareholders remained relatively stable at $1.6 billion for the three months ended September 30, 2025, compared to $1.4 billion in the prior year's quarter. This resilience in adjusted earnings was driven by positive market factors such as higher private equity returns and recurring investment income, as well as volume growth across segments like Asia and Latin America. However, underwriting adjustments and expense management were areas that presented challenges. The company's total assets grew to $719.7 billion, with a continued focus on managing its investment portfolio and capital resources.
Financial Highlights
38 data points| Revenue | $17.36B |
| Operating Expenses | $3.51B |
| Operating Income | $1.65B |
| Net Income | $896.00M |
| EPS (Basic) | $1.23 |
| EPS (Diluted) | $1.22 |
| Shares Outstanding (Basic) | 664.70M |
| Shares Outstanding (Diluted) | 669.10M |
Key Highlights
- 1Net income available to common shareholders decreased to $818 million in Q3 2025 from $1.3 billion in Q3 2024.
- 2Diluted earnings per common share fell to $1.22 in Q3 2025 from $1.81 in Q3 2024.
- 3Adjusted earnings available to common shareholders were $1.6 billion in Q3 2025, compared to $1.4 billion in Q3 2024.
- 4Total assets increased to $719.7 billion as of September 30, 2025, up from $677.5 billion as of December 31, 2024.
- 5The company's net investment gains were unfavorable by $248 million (net of tax) in Q3 2025 compared to Q3 2024.
- 6Net derivative gains (losses) were unfavorable by $1.7 billion (net of tax) in Q3 2025 compared to Q3 2024.
- 7MetLife completed an initial reinsurance transaction with Chariot Re on July 1, 2025.